EichorEICHOR
Study identifier: NCT03151629 Synced from ClinicalTrials.gov · August 02, 2026
● Recruiting

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

Condition: Prostate Cancer  ·  Sponsor: Prostate Cancer Clinical Trials Consortium

PhaseN/A
Planned participants5000
Who can joinMale, 21 Years to no upper limit
Healthy volunteersNo

About this study

Our intent is to establish the International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) as a prospective, international cohort of minimum 5,000 men with advanced cancer, including men with mHSPC and M0/M1 CRPC. The goal is to establish a population-based registry and recruit patients across academic and community practices from Australia, Barbados, Brazil, Canada, Ireland, Jamaica, Kenya, Nigeria, Norway, Spain, South Africa, Sweden, Switzerland, the United Kingdom (UK), and the United States (US). Target accrual number and number of participating sites are subject to change based on accrual, funding, and interest in participation by other international sites. This cohort study will facilitate a better understanding of the variation in care and treatment of advanced prostate cancer across countries and across academia and community based practices. Detailed data will be collected from patients at study enrollment and then during follow-up, for a minimum of five years. Patients will be followed prospectively for overall survival, clinically significant adverse events, comorbidities, changes in cancer treatments, and PROMs. PROMs questionnaires will be collected at enrollment and every three months thereafter. Physician Questionnaires will be collected from all participating sites at patient enrollment, time of first change in treatment and/or one year follow-up, at each subsequent change of treatment, and discontinuation of treatment. As su…

This description comes directly from the study's public registry record.

Talk to the study team

Jacob Vinson  ·  646-888-0421  ·  pcctcironmanregistry@mskcc.org

Always discuss trial participation with your own doctor first.

Locations (121)

University of Alabama-BirminghamBirmingham, Alabama, United StatesCompleted
University of Alabama- TuscaloosaTuscaloosa, Alabama, United StatesRecruiting
University of California - Los AngelesLos Angeles, California, United StatesTerminated
University of California San DiegoSan Diego, California, United StatesRecruiting
Yale UniversityNew Haven, Connecticut, United StatesRecruiting
University of FloridaGainesville, Florida, United StatesTerminated
Mayo Clinic JacksonvilleJacksonville, Florida, United StatesRecruiting
Moffitt Cancer CenterTampa, Florida, United StatesRecruiting
Morehouse School of MedicineAtlanta, Georgia, United StatesRecruiting
Emory Winship Cancer InstituteAtlanta, Georgia, United StatesRecruiting
University of Illinois at ChicagoChicago, Illinois, United StatesRecruiting
Robert H. Lurie Comprehensive Cancer Center of Northwestern UniversityChicago, Illinois, United StatesRecruiting

+ 109 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →